Breaking News1 year ago
Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression
[ad_1] BYLINE: Denise Heady Newswise — Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients...
